A novel function of benzyl isothiocyanate in vascular smooth muscle cells: The role of ERK1/2, cell cycle regulation, and matrix metalloproteinase-9

Journal of Cellular Physiology

Volumn 203, Issue 3, 2005, Pages 493-500

  Lee, Jin Young ^a   Moon, Sung Kwon ^b   Hwang, Cher Won ^c   Nam, Kyung Soo ^d   Kim, Yeon Kye ^e   Yoon, Ho Dong ^e   Kim, Min Gon ^f   Kim, Cheorl Ho ^a,g  

^a Dongguk University   (South Korea)

^b Chungju National University   (South Korea)

^c Handong University   (South Korea)

^d Dongguk University College of Medicine   (South Korea)

^e National Fisheries Research and Development Institute (NFRDI)   (South Korea)

^f Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^g Dongguk University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYL ISOTHIOCYANATE; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN SECRETION; SMOOTH MUSCLE FIBER; TRANSCRIPTION REGULATION; UPREGULATION; VASCULAR SMOOTH MUSCLE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL CYCLE; CELL CYCLE PROTEINS; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASES; CYCLINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GROWTH INHIBITORS; HUMANS; ISOTHIOCYANATES; MATRIX METALLOPROTEINASE 9; MUSCLE, SMOOTH, VASCULAR; NF-KAPPA B; PROMOTER REGIONS (GENETICS); TRANSCRIPTION FACTOR AP-1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 18244399845     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20257     Document Type: Article

References (49)

1. Abedi H, Zachary I. 1995. Signalling mechanisms in the regulation of vascular cell migration. Cardiovasc Res 30:544-556.
2. Bendeck MP, Zempo N, Clowes AW, Galardy RE, Reidy MA. 1994. Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ Res 75:539-545.
3. Bond M, Fabunmi RP, Baker AH, Newby AC. 1998. Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: An absolute requirement for transcription factor NF-kappa B. FEBS Lett 435:29-34.
4. Chen YR, Wang WF, Kong A-NT, Tan TH. 1998. Molecular mechanisms of c-Jun N-terminal kinase-mediated apoptosis induced by anticarcinogenic isothiocyanates. J Biol Chem 273:1769-1775.
5. Cho A, Reidy MA. 2002. Matrix metalloproteinase-9 is necessary for the regulation of smooth muscle cell replication and migration after arterial injury. Circ Res 91:845-851.
6. Cho A, Graves J, Reidy MA. 2000. Mitogen-activated protein kinases mediate matrix metalloproteinase-9 expression in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 20:2527-2532.
7. Chung FL, Morse MA, Eklind KI, Lewis J. 1992. Quantitation of human uptake of the anticarcinogen phenylethyl isothiocyanate after a watercress meal. Cancer Epidemiol Biomarker Prev 1:383-388.
8. Chung FL, Conaway CC, Rao CV, Reddy BS. 2000. Chemoprevention of colonic aberrant crypt foci in Fisher rats by sulforaphane and phenylethyl isothiocyanate. Carcinogenesis 21:2287-2291.
9. Chung TW, Lee YC, Kim CH. 2004. Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K/ AKT pathways: Involvement of invasive potential. FASEB J 18(10):1123-1125.
10. Clausell N, De Lima VC, Molossi S. 1995. Expression of tumor necrosis factor alpha and accumulation of fibronectin in coronary artery restenotic lesions retrieved by atherectomy. Br Heart J 73:534-539.
11. Cobb MH, Goldsmith EJ. 1995. How MAP kinases are regulated. J Biol Chem 270:14843-14846.
12. Criska E, Piskula M, Wazczuk K, Kozowaska H. 1994. Glucosinolates in cruciferous vegetables grown in Poland In: Kozowaska H, Fornal J, Zdunczyk Z, editors. Bioactive substances in food of plant origin. Olsztyn, Poland: Polish Academy of Science. Vol. 1. pp 25-30.
13. Davis RJ. 1993. The mitogen-activated protein kinase signal transduction pathway. J Biol Chem 268:14553-14556.
14. Dick RA, Kensler TW. 2002. Chemopreventive potential of phase 2 enzyme inducers. Expert Rev Anticancer Thre 2:581-592.
15. Dollery CM, McEwan JR, Henney AM. 1995. Matrix metalloproteinases and cardiovascular disease. Circ Res 77:863-868.
16. Fabunmi RP, Baker AH, Murray EJ, Booth RFG, Newby AC. 1996. Divergent regulation by growth factors and cytokines of 95 kDa and 72 kDa gelatinases and tissue inhibitors or metalloproteinases-1, -2, and -3 in rabbit aortic smooth muscle cells. Biochem J 315:335-342.
17. Farina AR, Tacconelli A, Vacca A, Maroder M, Gulino A, Mackay AR. 1999. Transcriptional up-regulation of matrix metalloproteinase-9 expression during spontaneous epithelial to neuroblast phenotype conversion by SK-N-SH neuroblastoma cells, involved in enhanced invasivity, depends upon GT-box and nuclear factor kappaB elements. Cell Growth Differ 10:353-367.
18. Fini ME, Bartlett JD, Matsubara M, Rinehart WB, Mody MK, Girard MT, Rainville M. 1994. The rabbit gene for 92-kDa matrix metalloproteinase. Role of AP1 and AP2 in cell type-specific transcription. J Biol Chem 269:28620-28628.
19. Galis ZS, Johnson C, Godin D, Magid R, Shipley JM, Senior RM, Ivan E. 2002. Targeted disruption of the matrix metalloproteinase-9 gene impairs smooth muscle cell migration and geometrical arterial remodeling. Circ Res 91:852-859.
20. Gamet-Payrastre L, Li P, Lumeau S, Cassar G, Dupont MA, Chevolleau S, Gasc N, Tulliez J, Terce F. 2000. Sulforaphane, a naturally occurring isothiocyanate, induces cell cycle arrest and apoptosis in HT29 human colon cancer cells. Cancer Res 60:1426-1433.
21. Gardner PD, Haynes GR, Brandon RL. 1957. Formation of Diekmann reaction products under acyloin conditions; Competition of the two reactions. J Org Chem 22:1206-1210.
22. Gordon D, Reidy MA, Benditt EP. 1990. Cell proliferation in human coronary arteries. Proc Natl Acad Sci USA 87:4600-4604.
23. Gum R, Lengyel E, Juarez J, Chen JH, Sato H, Seiki M, Boyd D. 1996. Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences. J Biol Chem 271:10672-10680.
24. Jovinge S, Ares MP, Kallin B, Nilsson J. 1996. Human monocyte/macrophages release TNF-alpha in response to Ox-LDL. Arterioscler Thromb Vasc Biol 16:1573-1579.
25. Jovinge S, Hultgardh-Nilsson A, Regnstrom J, Nilsson J. 1997. TNF-alpha activates smooth muscle cell migration in culture and is expressed in the balloon-injured rat aorta. Arterioscl Thromb Vasc Biol 17:490-497.
26. Libby P, Sukhova G, Lee RT, Galis ZS. 1995. Cytokines regulate vascular functions related to stability of the atheroscerotic plaque. J Cardiovasc Pharmacol 25:9-12.
27. Macleod KF, Sherry N, Hannon G, Beach D, Tokino T, Kinzler K, Vogelstein B, Jacks T. 1995. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev 9:935-944.
28. Maheo K, Morel F, Langout S, Kramer H, Le Ferrec E, Ketterer B, Guillauzo A. 1997. Inhibition of cytochrome P-450 and induction of glutathione S-transferase by sulforaphane in primary human and rat hepatocytes. Cancer Res 57:3649-3652.
29. Moon SK, Thompson LJ, Mandamachi N, Ballinger S, Papaconstantinou J, Horaist C, Runge MS, Patterson C. 2001. Aging, oxidative response, and proliferative capacity in cultured aortic smooth muscle cells. Am J Physiol Heart Circ Physiol 280:H2779-H2788.
30. Moon SK, Cho GO, Jung SY, Gal SW, Kwon TK, Lee YC, Madamanchi NR, Kim CH. 2003. Quercetin exerts multiple inhibitory effects in vascular smooth muscle cells: Role of ERK1/2, cell-cycle regulation, and matrix metalloproteinase-9. Biochem Biophys Res Commun 301:1069-1078.
31. Moon SK, Cha BY, Kim CH. 2004. ERK1/2 mediates TNF-α-induced matrix metalloproteinase-9 expression in human vascular smooth muscle cells via the regulation of NF-κB and AP-1: Involvement of the Ras dependent pathway. J Cell Phys 198:417-427.
32. Nakamura Y, Morimitsu Y, Uzu Y, Ohigashi H, Murakami H, Kawai K, Osawa T, Uchida K. 2000. A glutathione S-transferase inducer from papaya: Rapid screening, identification and structure-activity relationship of isothiocyanates. Cancer Lett 157:193-200.
33. Nakamura Y, Kawakami M, Yoshihiro A, Miyoshi N, Ohigashi H, Kawai K, Osawa T, Uchida K. 2002. Involvement of the mitochondrial death pathway in chemopreventive benzyl isothiocyanate-induced apoptosis. J Biol Chem 277:8492-8499.
34. Newby AC, Zaltsman AB. 2000. Molecular mechanisms in intimal hyperplasia. J Pathol 190:300-309.
35. Okada Y, Gonoji Y, Naka K, Tomita K, Nakanishi I, Iwata K, Yamashita K, Hayakawa T. 1992. Matrix metalloproteinase 9 (92-kDa) gelatinase/type IV collagenase from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties. J Biol Chem 267:21712-21719.
36. Ross R. 1993. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 362:801-809.
37. Ross R. 1995. Cell biology of atherosclerosis. Annu Rev Physio 57:791-804.
38. Sato H, Seiki M. 1993. Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 8:395-405.
39. 1 phase progression: Cycling on cue. Cell 79:551-555.
40. Sherr CJ. 1996. Cancer cell cycles. Science 274:1672-1677.
41. Srivastava SK, Xiao D, Lew KL, Hershberger P, Kokkinakis DM, Johnson CS, Trump DL, Singh SV. 2003. Allyl isothiocyanate, a constituent of cruciferous vegetables inhibits growth of PC-3 human prostate cancer xenografts in vivo in association with down regulation of Bcl-2 and Cdc25C. Carcinogenesis 24:1665-1670.
42. 1 cyclin-cdk protein kinase activity, is related to p21. Cell 78:67-74.
43. Weiss RH, Joo A, Randour C. 2000. p21 (Waf1/Cip1) is an assembly factor required for platelet-derived growth factor-induced vascular smooth muscle cell proliferation. J Biol Chem 275:10285-10290.
44. Xiao D, Singh SV. 2002. Phenylethyl isothiocyanate-induced apoptosis in p53-deficient PC-3 human prostate cancer cell line is mediated by extracellular signal-regulated kinases. Cancer Res 62:3615-3619.
45. 2/M arrest and inducing apoptosis. Carcinogenesis 24:891-897.
46. Xu K, Thornalley PJ. 2000. Studies on the mechanism of the inhibition of human leukemia cell growth by dietary isothiocyanates and their cysteine adducts in vitro. Biochem Pharmacol 60:221-231.
47. Yan C, Wang H, Bond DD. 2001. KiSS-1 represses 92-kDa type IV collagenase expression by down regulating NF-kappa B binding to the promoter as a consequence of Ikappa Balpha -induced block of p65/p50 nuclear translocation. J Biol Chem 276:1164-1172.
48. Ye L, Zhang Y. 2001. Total intracellular accumulation levels of dietary isothiocyanate determine their activity in elevation of cellular glutathione and induction of phase 2 detoxification enzymes. Carcinogenesis 22:1987-1992.
49. Zhang Y. 2001. Molecular mechanism of rapid cellular accumulation of anticarcinogenic isothiocyanates. Carcinogenesis 22:425-431.